Preliminary real-world data suggests that these medications may reduce progression to chronic kidney disease, potentially by inhibiting the NF-kB inflammatory pathway that drives renal damage
The retatrutide 9 mg group lost an average of 26.4%, and the placebo group lost 2.1%
Disease-modifying medications control major flares, but baseline joint stiffness and pain persist, particularly in the hands and wrists
Phase 3 studies have shown an improvement in lipid parameters and liver enzymes
Antioxidant and Anti-Aging Support Essential vitamins and minerals help reduce oxidative stress and support healthy cellular function
Biogenesis of Exos Unlike microvesicles, which are formed through direct outward budding from the plasma membrane, Exos are specifically created within multivesicular bodies (MVBs) through the endolysosomal pathway [50, 65]